Thus, we compared the genome-wide expression patterns of matched (for the variables of: complicated outcome; gender; AIS; number of samples isolated at the same time points; and whether the patient died during hospitalization) patients with complicated outcomes.
The factors significantly associated with outcome (gender, age, comorbidities, residence, level of education, hospital stay) were selected by a bootstrap stepwise procedure and their Risks Ratio (RR) were estimated through a multivariate regression model.
In order to achieve a balanced allocation of control and intervention communities with respect to covariates hypothesized to be associated with the primary outcome, gender norms, a restricted randomization scheme was employed [ 36].
Logistic regression was used to compare odds ratios for development of the primary outcome and adjustments were made for variables associated with the primary outcome: gender, age, MODS score at admission, mechanical ventilation at admission, total number of transfusions and total dose of transfusion.
We considered the following ten possible risk factors for surgical outcome: gender, age, history of previous PRP, history of cataract surgery, history of vitrectomy, concurrent vitrectomy, preoperative IVB, NVG in the fellow eye, postoperative hyphema, postoperative choroidal detachment, and postoperative formation of fibrin.
Using logistic regression, the following potential prognostic factors were investigated for possible association with the response outcome: gender, smoking history, age at diagnosis, number of lines of prior chemotherapy, performance status using the ECOG Eastern Cooperative Oncology Groupp) scale, and histology.
Among study outcomes, gender appears to have the least relevance for jail outcomes.
The following sociodemographic variables were analyzed as potential determinants of mental health outcomes: gender (male, female) and age (25 44, 45 64 years old).
When assessing the relationship between gap density and binary outcomes (gender, need for TNF agents), the Wilcoxon rank sum test was used.
The study compared outcomes (gender of patient, drugs prescribed and their cost) in the intervention and comparison sites during 3 time periods: before (January 1997-July 2000) during (August 2000-September 2003) and after the intervention (October 2003-December 2006).
In all multivariable models, gender, ASA class, type of admission and presence of malignancy were included as covariables except for the outcomes gender (where gender is excluded as a covariable), admission type (where admission type is excluded as a covariable) and presence of malignancy (where presence of malignancy is excluded as a covariable).
